Viewing Study NCT03069534


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-04-18 @ 6:38 AM
Study NCT ID: NCT03069534
Status: UNKNOWN
Last Update Posted: 2017-03-03
First Post: 2017-02-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module